AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
基本信息
- 批准号:2743533
- 负责人:
- 金额:$ 20.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-01 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:age difference cell senescence cellular pathology cellular respiration endopeptidases enzyme activity enzyme inhibitors free radicals histology immunochemistry laboratory rat lipid peroxides lipids mass spectrometry mitochondria myocardial ischemia /hypoxia oxidative stress peroxidation posttranslational modifications protein localization protein purification protein structure function reperfusion respiratory enzyme superoxides
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Reperfusion of
cardiac tissue results in declines in mitochondrial respiration, the
severity of which increases with age. Critical to the energy status and
function of the heart, cardiac mitochondria exhibit reperfusion-induced
increases in free radical production. A direct link between free
radicals and mitochondrial dysfunction has yet to be established. 4-
Hydroxy-2-nonenal (HNE), a major product of lipid peroxidation readily
reacts with and inactivates enzymes. Work from the Principal
Investigator's laboratory had established that reperfusion results in
modification of specific proteins by HNE. The level of HNE modification
increases with age and parallels declines in mitochondrial respiration.
Treatment of intact cardiac mitochondria with concentrations of HNE
expected during reperfusion causes rapid declines in NADH-dependent
respiration similar to that observed during reperfusion. The Principal
Investigator thus proposes that: Reperfusion-induced declines in
mitochondrial respiration are due, in part, to modification of specific
mitochondrial proteins(s) by HNE and that these processes contribute to
age-related increases in myocardial reperfusion injury.
To test this hypothesis, hearts isolated from rats of different ages
will be subjected to varying durations of ischemia and reperfusion.
Mitochondria will then be isolated to determine:
1. Specific respiratory enzymes inactivated during ischemia and
reperfusion.
2. The identities of mitochondrial protein(s) modified by HNE and the
level of HNE modification.
3. Changes in mitochondrial susceptibility to HNE damage and superoxide
anion generation.
Chemical, immunochemical, and mass spectroscopic techniques will be
utilized to detect and purify HNE-modified protein. Relationships
between the level and identity of mitochondrial proteins modified by HNE
(Aim 2) and those exhibiting reperfusion-induced declines in activity
(Aim 1) will define mechanisms responsible for loss in mitochondrial
function during reperfusion. Determinants of HNE-mediated damage to
mitochondria will be established by evaluating changes in mitochondrial
properties which occur during aging and ischemia (Aim 1) and result in
elevated rates of HNE formation and/or increased susceptibility of
specific respiratory enzymes to modification (Aim 3). Identification of
specific mechanisms of myocardial reperfusion injury and conditions
under which they occur is necessary if intervention is to be achieved.
描述(改编自申请人的摘要):
心脏组织导致线粒体呼吸下降,
其严重性随着年龄的增长而增加。对能源状况至关重要,
心脏的功能,心肌线粒体表现出再灌注诱导
增加自由基的产生。自由之间的直接联系
自由基和线粒体功能障碍尚未建立。4-
羟基-2-壬烯醛(HNE)是脂质过氧化的主要产物,
与酶反应并使酶失活。来自校长的工作
研究人员的实验室已经确定,再灌注导致
通过HNE修饰特定蛋白质。HNE改性水平
随着年龄的增长而增加,并与线粒体呼吸的下降平行。
用一定浓度的HNE处理完整的心肌线粒体
预期在再灌注过程中,
呼吸类似于再灌注期间观察到的。校长
因此,研究者提出:再灌注诱导的
线粒体呼吸的部分原因是由于特定的
线粒体蛋白(S)的HNE和这些过程有助于
年龄相关的心肌再灌注损伤增加。
为了验证这一假设,从不同年龄的大鼠中分离出心脏,
将经受不同持续时间的缺血和再灌注。
然后分离线粒体以确定:
1.在缺血期间失活的特异性呼吸酶,
再灌注
2.经HNE修饰的线粒体蛋白质的身份和经HNE修饰的线粒体蛋白质的身份。
HNE改性水平。
3.线粒体对HNE损伤和超氧化物敏感性的变化
负离子生成
化学、免疫化学和质谱技术将被广泛应用。
用于检测和纯化HNE修饰的蛋白。关系
HNE修饰的线粒体蛋白质的水平和特性之间
(Aim 2)和那些表现出再灌注诱导的活性下降的
(Aim 1)将定义负责线粒体损失的机制
再灌注期间的功能。HNE介导的损伤的决定因素
线粒体将通过评估线粒体的变化来建立。
在老化和局部缺血期间发生的性质(目的1),并导致
HNE形成率升高和/或HNE敏感性增加
特异性呼吸酶的修饰(目的3)。鉴定
心肌再灌注损伤的特殊机制和条件
如果要进行干预,就必须确定它们发生的条件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LUKE I. SZWEDA其他文献
LUKE I. SZWEDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LUKE I. SZWEDA', 18)}}的其他基金
Diversity Supplement-Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
多样性补充-氧化DNA损伤调节心肌细胞增殖
- 批准号:
9898738 - 财政年份:2018
- 资助金额:
$ 20.71万 - 项目类别:
Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
DNA 氧化损伤调节心肌细胞增殖
- 批准号:
9921473 - 财政年份:2018
- 资助金额:
$ 20.71万 - 项目类别:
Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
DNA 氧化损伤调节心肌细胞增殖
- 批准号:
9752677 - 财政年份:2018
- 资助金额:
$ 20.71万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
6478574 - 财政年份:2002
- 资助金额:
$ 20.71万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
6625766 - 财政年份:2002
- 资助金额:
$ 20.71万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
7020621 - 财政年份:2002
- 资助金额:
$ 20.71万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
6743130 - 财政年份:2002
- 资助金额:
$ 20.71万 - 项目类别:
Modulation of Mitochondrial Function by Pro-Oxidants
促氧化剂对线粒体功能的调节
- 批准号:
7897640 - 财政年份:1999
- 资助金额:
$ 20.71万 - 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
- 批准号:
6626440 - 财政年份:1999
- 资助金额:
$ 20.71万 - 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
- 批准号:
6488849 - 财政年份:1999
- 资助金额:
$ 20.71万 - 项目类别:
相似海外基金
Role of endothelial cell senescence in age-related cardiomyopathy
内皮细胞衰老在年龄相关性心肌病中的作用
- 批准号:
10726050 - 财政年份:2023
- 资助金额:
$ 20.71万 - 项目类别:
Role of ATII cell senescence in influenza pathogenesis in aging
ATII细胞衰老在流感发病机制中的作用
- 批准号:
10741215 - 财政年份:2023
- 资助金额:
$ 20.71万 - 项目类别:
Elucidation of cell senescence-associated porphyrin metabolism affecting ami nolevulinic acid-photodynamic diagnosis for cancer
阐明细胞衰老相关的卟啉代谢影响氨基乙酰丙酸光动力诊断癌症
- 批准号:
23K14619 - 财政年份:2023
- 资助金额:
$ 20.71万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Canagliflozin Inhibits Hedgehog Interacting Protein (Hhip)-Mediated Renal Tubular Cell Senescence in Type 1 Akita Mice
Canagliflozin 抑制 1 型秋田小鼠中刺猬相互作用蛋白 (Hhip) 介导的肾小管细胞衰老
- 批准号:
495301 - 财政年份:2023
- 资助金额:
$ 20.71万 - 项目类别:
Cell Senescence Regulating Osteoarthritis Progression: Sex-dependent Mechanisms
细胞衰老调节骨关节炎进展:性别依赖性机制
- 批准号:
10567551 - 财政年份:2023
- 资助金额:
$ 20.71万 - 项目类别:
Beating mesenchymal stem cell senescence with materials that organise growth factors.
用组织生长因子的材料对抗间充质干细胞衰老。
- 批准号:
2889027 - 财政年份:2023
- 资助金额:
$ 20.71万 - 项目类别:
Studentship
Excessive lipid metabolism in T cell senescence and immunosuppression
T细胞衰老和免疫抑制中的过度脂质代谢
- 批准号:
10735675 - 财政年份:2023
- 资助金额:
$ 20.71万 - 项目类别:
Metabolic Control of T Cell Senescence in Pathogenesis and Immunotherapy of Alzheimer's Disease
阿尔茨海默病发病机制和免疫治疗中 T 细胞衰老的代谢控制
- 批准号:
10516392 - 财政年份:2022
- 资助金额:
$ 20.71万 - 项目类别:
Telomere uncapping as a novel mechanism for endothelial cell senescence and age-related arterial dysfunction
端粒脱帽是内皮细胞衰老和年龄相关动脉功能障碍的新机制
- 批准号:
10389795 - 财政年份:2022
- 资助金额:
$ 20.71万 - 项目类别:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
耶鲁小鼠-TMC 对免疫细胞衰老引起的炎症的研究
- 批准号:
10675111 - 财政年份:2022
- 资助金额:
$ 20.71万 - 项目类别:














{{item.name}}会员




